L009-0633 Screening compound: 3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

L009-0633 Screening compound: 3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide
L009-0633 Screening compound: 3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L009-0633
3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L009-0633

Molecular Formula

C28H27N5O2 (C28 H27 N5 O2)

Compound Name

3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

IUPAC name

3-[6-(benzylamino)pyridazin-3-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

SMILES

O=C(c1cc(-c(cc2)nnc2NCc2ccccc2)ccc1)Nc(cc1)ccc1N1CCOCC1

InChI

InChI=1S/C28H27N5O2/c34-28(30-24-9-11-25(12-10-24)33-15-17-35-18-16-33)23-8-4-7-22(19-23)26-13-14-27(32-31-26)29-20-21-5-2-1-3-6-21/h1-14,19H,15-18,20H2,(H,29,32)(H,30,34)

InChI Key

CMQLTMSDRYSNAQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27226081

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.093

Distribution Coefficient, logD

4.093

Water Solubility, LogSw

-4.30

Polar Surface Area

66.964

Acid Dissociation Constant (pKa)

11.44

Base Dissociation Constant (pKb)

6.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.90

L009-0633 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L009-0633 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L009-0633?
Check Price and Availability of L009-0633, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L009-0633 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L009-0633
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L009-0633
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L009-0633 available by request